(Press-News.org) Honey bee populations have been mysteriously falling for at least five years in the United States, but the cause of so-called colony collapse disorder (CCD) is still largely unknown.
In a report published Nov. 2 in the online journal PLoS ONE, researchers report that a widely used in-hive medication may make bees more susceptible to toxicity of commonly used pesticides, and that this interaction may be at least partially responsible for the continuing honey bee population loss.
The researchers, led by David Hawthorne of University of Maryland, pre-treated healthy honey bees with the antibiotic oxytetracycline, and then exposed the bees to two pesticides that are commonly used in bee hives to control parasitic varroa mites. In both cases, the pre-treated bees were much more sensitive to pesticide exposure than were bees that had not been treated.
The team suspected that oxytetracycline may interact with specific bee proteins called multiple drug resistance (MDR) transporters, making them less effective and therefore rendering the bee more at risk to the pesticides. To test this hypothesis, they pre-treated the bees with another drug, verapamil, which is known to inhibit a particular MDR transporter. These insects showed increased sensitivity to five different pesticides, supporting the group's theory that MDR transporters, and specific combinations of independently safe chemicals, may play an important role in CCD.
###
Citation: Hawthorne DJ, Dively GP (2011) 'Killing Them with Kindness? In-Hive Medications May Inhibit Xenobiotic Efflux Transporters and Endanger Honey Bees'. PLoS ONE 6(11): e26796. doi:10.1371/journal.pone.0026796
Financial Disclosure: This work was supported by the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interest Statement: The authors have declared that no competing interests exist.
A widely used bee antibiotic may harm rather than help
2011-11-03
ELSE PRESS RELEASES FROM THIS DATE:
Born to roar
2011-11-03
Lions' and tigers' fearsome roars are due to their unusual vocal cords, according to a study published in the Nov. 2 issue of the online journal PLoS ONE. The authors report that the big cats' vocal cards have an odd square shape and can withstand strong stretching and shearing. That shape "makes it easier for the tissue to respond to the passing airflow," allowing louder roars at lower lung pressure, says University of Utah researcher Tobias Riede, one of the researchers involved in the project.
These findings contradict a theory that lions roar deeply because the vocal ...
Mayo researchers discover tactic to delay age-related disorders
2011-11-03
ROCHESTER, Minn. -- Researchers at Mayo Clinic (http://www.mayoclinic.org) have shown that eliminating cells that accumulate with age could prevent or delay the onset of age-related disorders and disabilities. The study, performed in mouse models, provides the first evidence that these "deadbeat" cells could contribute to aging and suggests a way to help people stay healthier as they age. The findings appear in the journal Nature,(http://www.nature.com/nature/index.html) along with an independent commentary on the discovery.
"By attacking these cells and what they produce, ...
Increased use of bikes for commuting offers economic, health benefits
2011-11-03
MADISON – Cutting out short auto trips and replacing them with mass transit and active transport would yield major health benefits, according to a study just published in the scientific journal Environmental Health Perspectives. The biggest health benefit was due to replacing half of the short trips with bicycle trips during the warmest six months of the year, saving about $3.8 billion per year from avoided mortality and reduced health care costs for conditions like obesity and heart disease.
The report calculated that these measures would save an estimated $7 billion, ...
H. Lewis Smith, President/CEO, United Voices for a Common Cause, Inc. Reflects on an Upcoming PBS Documentary "Slavery By Another Name"
2011-11-03
Laurence Fishburne will be the narrator of an upcoming PBS documentary about black workers in the post-slavery South. The film, titled "Slavery by Another Name," is based on the Pulitzer Prize-winning book by Douglas A. Blackmon. Blackmon's composition is a powerful account of how America surreptitiously maintained slavery under the guise of peonage and forced labor from 1863 to the 1960s.
The narrative brings to light one of the darkest and most shameful moments in American history, exposing the awful truth about the interminable abuse of power and continued ...
Jawbone found in England is from the earliest known modern human in northwestern Europe
2011-11-03
A piece of jawbone excavated from a prehistoric cave in England is the earliest evidence for modern humans in Europe, according to an international team of scientists. The bone first was believed to be about 35,000 years old, but the new research study shows it to be significantly older -- between 44,000 and 41,000 years old, according to the findings that will be published in the journal Nature. The new dating of the bone is expected to help scientists pin down how quickly the modern humans spread across Europe during the last Ice Age. It also helps confirm the much-debated ...
Young and old work together to challenge stereotypes of age
2011-11-03
The workshops, entitled 'Act your Age! Challenging Stereotypes', form part of the Economic and Social Research Council's (ESRC) Festival of Social Science 2011 and are organised by the University of Sheffield's New Dynamics of Ageing (NDA) research programme.
Sarah Howson and Charlotte Jones, who are co-ordinating the workshops, say: "Stereotyping in the media can lead to a negative understanding of older people. The workshop will use a variety of hands-on activities to help the children to consider their perceptions of older people. They will be asked to apply these ...
New therapy marks a milestone in fight against cystic fibrosis
2011-11-03
CLEVELAND -- Results of the pivotal Phase 3 clinical trial published in the Nov. 3, 2011 (embargoed 5 pm ET, Nov. 2, '11) New England Journal of Medicine, find that the oral medication ivacaftor (VX-770) provides major, sustained improvement in lung function, growth and other signs and symptoms for cystic fibrosis (CF) patients. The multi-site study marks the first time a drug has been shown to work on the disease process rather than on the symptoms. CF, which has no cure, is the most common lethal genetic disease in Caucasians.
"Ivacaftor represents a significant advancement ...
Thousands of lives could be saved if rest of UK adopted average diet in England
2011-11-03
Around 4,000 deaths could be prevented every year if the UK population adopted the average diet eaten in England, concludes research published in BMJ Open.
Death rates for cardiovascular disease and cancer are higher in Scotland, Wales, and Northern Ireland than they are in England, and it is well known that these diseases are associated with a poor diet that is high in saturated fats and salt and low in fibre, fruits and vegetables.
The researchers therefore looked at mortality data for coronary heart disease, stroke, and 10 cancers associated with diet, including ...
Disco beat good for CPR, but time to throw in the towel on musical aids
2011-11-03
Disco Science is better than no music at all at helping to deliver the required number of chest compressions (CPR) to save a heart attack victim's life before s/he gets to hospital, reveals research published online in Emergency Medicine Journal.
But Disco Science, which featured in the soundtrack to Guy Ritchie's film Snatch in 2000, still doesn't improve the depth of compression, leading the authors to suggest that it's time to give up on trying to find the best musical track to aid the procedure.
The annual UK incidence of heart attacks occurring outside hospital ...
Radiation plus hormone therapy greatly improves survival
2011-11-03
(Toronto – Nov. 3, 2011) – Men with locally advanced or high-risk prostate cancer who receive combined radiation and hormone therapy live longer and are less likely to die from their disease, shows clinical research led by radiation oncologists at the Princess Margaret Hospital (PMH) Cancer Program, University Health Network.
The findings are published online today in The Lancet (doi: 10.1016/S0140-6736(11)61095-7). Principal investigator Padraig Warde, deputy head, PMH radiation medicine program, says: "The study shows combining radiation and hormone therapy improves ...